STX-1400

N/A

Report date: 2024/12/17 13:35:29

Base Information

Drug NameSTX-1400
Drug Alias NameSTX-1400STX1400
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionApolipoprotein C-III inhibitors
TargetsApolipoprotein C-III
Therapy Area/IndicationsHypertriglyceridemiaHyperlipoproteinemia Type I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScribe Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesScribe Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemiaHyperlipoproteinemia Type I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A